Crossmark

Safety and efficacy of sorafenib in Japanese patients with hepatocellular carcinoma in clinical practice: a subgroup analysis of GIDEON

Crossref DOI link: https://doi.org/10.1007/s00535-016-1204-2

Published Online: 2016-04-22

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kudo, Masatoshi

Ikeda, Masafumi

Takayama, Tadatoshi

Numata, Kazushi

Izumi, Namiki

Furuse, Junji

Okusaka, Takuji

Kadoya, Masumi

Yamashita, Satoshi

Ito, Yuichiro

Kokudo, Norihiro
Funding

Funding for this research was provided by:

Bayer Yakuhin, Ltd.
License Information

License valid from 2016-04-22